SCHEMBL7407490

SCHEMBL7407490

CC(C)(Cc1ccccc1)c1cc(O)c(Cc2ccccc2C2CC2)c(=O)o1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 2/20 0.35
JAK2 O60674 1/20 0.35
POLB P06746 1/20 0.35
PKM P14618 1/20 0.35
MAPK1 P28482 1/20 0.35
MPI P34949 1/20 0.35
HTT P42858 1/20 0.35
BLM P54132 1/20 0.35
MCL1 Q07820 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 1/20 0.35
NQO1 P15559 3/20 0.34
SHBG P04278 1/20 0.34
CNR2 P34972 6/20 0.34
GPR55 Q9Y2T6 4/20 0.34
CNR1 P21554 4/20 0.34
GPR18 Q14330 3/20 0.34
HSD17B3 P37058 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7405496 0.90 CNR2 (0.35) KDM4EMAPTGAAJAK2POLB
SCHEMBL8437700 0.88 KDM4E (0.34) KDM4EMAPTGAAJAK2POLB
SCHEMBL7376729 0.85 NR3C1 (0.33) KDM4EMAPTGAAJAK2POLB
SCHEMBL7402484 0.82 CNR1 (0.34) KDM4EMAPTGAAJAK2POLB
SCHEMBL8434645 0.81 NR3C1 (0.32) KDM4EMAPTGAAJAK2POLB
SCHEMBL6177242 0.76 TYR (0.35) KDM4EMAPTGAAJAK2POLB
SCHEMBL6174140 0.72 CNR2 (0.34) POLBALDH1A1NQO1CNR2
SCHEMBL6174971 0.72 NQO1 (0.31) NQO1HSD17B3ESR1AR
SCHEMBL6175016 0.71 CEL (0.35) POLBMAPK1HTTSMN1; SMN2ALDH1A1
SCHEMBL7407485 0.71 CYP2C9 (0.34) KDM4EALDH1A1CNR2GPR55CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed